Lion’s Mane (Hericium erinaceus) and Reishi (Ganoderma lucidum) are among the most researched functional mushrooms. They appear together on countless supplement labels, and both have centuries of use in traditional East Asian medicine. Yet their bioactive compound profiles, primary research focus areas, and practical use cases are meaningfully different. Understanding those differences may help clarify which mushroom, or combination, is most relevant to a particular health goal.
Different Compounds, Different Mechanisms
The starting point for comparing these two species is their chemistry. While both contain beta-glucan polysaccharides with studied immunomodulatory properties, Lion’s Mane is uniquely recognized for two classes of diterpenoid compounds: hericenones, found in the fruiting body, and erinacines, found in the mycelium. These compounds have been shown in preclinical research to cross the blood-brain barrier and stimulate the synthesis of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), proteins essential for the growth, maintenance, and survival of neurons.
Reishi’s distinguishing compounds are its triterpenoids, specifically ganoderic acids and related structures. These require alcohol-based extraction to isolate, as they are not water-soluble. Research has focused on their potential anti-inflammatory, immunomodulatory, and adaptogenic properties, as well as possible effects on fatigue and stress-related symptoms. Reishi also contains high concentrations of beta-1,3/1,6-glucans, which are associated with immune receptor engagement through pattern-recognition pathways.
Where Lion’s Mane Research Is Strongest
The most substantiated use case for Lion’s Mane is cognitive and neurological health. A systematic review published in Neuroscience and Biobehavioral Reviews analyzed 34 human studies examining the effects of different mushrooms on neurocognition and mood across the lifespan. Intervention studies primarily investigated Lion’s Mane, and findings indicated some enhancement of mood and cognitive function in middle-aged and older adults, though the authors noted that results from intervention studies were mixed and that further adequately powered trials are needed.[1]
A narrative review in Nutrition Research Reviews examined the full body of evidence around H. erinaceus and Alzheimer’s disease specifically, including three human clinical trials and thirteen animal model studies. The authors found that across these studies, Lion’s Mane use was associated with positive findings in behavioral, histological, and biochemical assessments relevant to cognitive function. Erinacine-A-enriched mycelium extract appeared to demonstrate the highest bioactive potency among the studied preparations, with evidence suggesting relative ease of crossing biological barriers.[2]
Ongoing preclinical work has also examined Lion’s Mane in the context of nerve regeneration, demyelination, and mood-related pathways, with the erinacine compounds attracting particular attention for their neuroprotective potential. For readers specifically interested in Lion’s Mane’s research on nerve health and myelin, our overview of Lion’s Mane and neurological research covers those findings in detail.
Where Reishi Research Is Strongest
Reishi’s research base is broader in scope but often less neurologically focused. The most frequently cited clinical data involves fatigue, well-being, and general immune parameters. A randomized, double-blind, placebo-controlled study published in the Journal of Medicinal Food enrolled 132 patients with neurasthenia, a condition characterized by persistent fatigue, weakness, and difficulty concentrating. Patients receiving a Ganoderma polysaccharide extract (Ganopoly) for eight weeks showed significantly greater improvements in CGI severity scores and sense of fatigue compared to placebo, with 51.6 percent of the Ganopoly group rated as more than minimally improved versus 24.6 percent in the placebo group. The extract was well tolerated across the study period.[3]
Reishi triterpenoids have also been studied in the context of immune modulation, with research examining their potential influence on natural killer cell activity, macrophage function, and cytokine profiles. These findings are primarily preclinical, but they have informed its traditional classification as an adaptogen, a compound that may help the body respond to physiological stressors.
Key Differences at a Glance
Primary Research Focus
Lion’s Mane research has concentrated most heavily on neurological and cognitive health, with the hericenone and erinacine compounds providing mechanistic rationale for this direction. Reishi research has been broader, with notable clinical data around fatigue and well-being, and substantial preclinical work on immune-related pathways.
Compound Classes
Lion’s Mane is defined primarily by its NGF-stimulating diterpenoids. Reishi is defined by its ganoderic acid triterpenoids and high-molecular-weight beta-glucans. The triterpenoids in Reishi require alcohol extraction; Lion’s Mane diterpenoids and polysaccharides are typically obtained through hot water or dual extraction.
Extraction Considerations
For Lion’s Mane, fruiting body extracts standardized for hericenone content, or mycelium products standardized for erinacine content, are the forms with the most research support. For Reishi, a dual extract capturing both beta-glucans and triterpenoids is generally considered more comprehensive than a water-only extract. Neither mushroom should be consumed as raw whole mushroom powder if the goal is obtaining bioavailable quantities of these specific compounds, as beta-glucans require hot water extraction to be released from the fungal cell wall.
Who Might Prefer Each
Individuals whose primary interest is cognitive support, neurological resilience, or mood may find the existing research more directly applicable to Lion’s Mane, given the concentration of human and preclinical data in this area. Those whose primary interest relates to managing fatigue, supporting immune function, or adapting to physiological stress may find the Reishi evidence base more relevant, particularly given the controlled clinical data on fatigue and well-being.
It is also worth noting that these two mushrooms are frequently combined in multi-mushroom supplements. There is no documented negative interaction between them, and their distinct compound classes and mechanisms mean they are unlikely to compete for the same biological pathways. Whether combined use produces additive effects in humans is not yet well characterized in clinical research.
Practical Considerations
Product quality varies considerably across the commercial market for both mushrooms. Key considerations when evaluating a specific supplement include: whether the product specifies fruiting body versus mycelium source, whether beta-glucan content is stated separately from total polysaccharide content, whether triterpenoid content is declared for Reishi products, and whether a third-party Certificate of Analysis is available. Neither mushroom is associated with serious adverse effects at typical supplementation levels, though individuals taking immunosuppressants, anticoagulants, or blood sugar-lowering medications should consult a healthcare provider before beginning either.
Summary
Lion’s Mane and Reishi are complementary rather than competing. Lion’s Mane is distinguished by its NGF-stimulating diterpenoid compounds and a research focus centered on cognitive and neurological health. Reishi is distinguished by its triterpenoids and broader adaptogenic profile, with notable clinical evidence in fatigue and well-being. The most relevant choice depends on the individual’s specific health priorities, and both mushrooms have credible scientific literature supporting their respective areas of application.
References
- [1] Cha S, et al. A review of the effects of mushrooms on mood and neurocognitive health across the lifespan. Neurosci Biobehav Rev. 2024;158:105548. PMID: 38246232
- [2] Cornford N, Charnley M. Hericium erinaceus: A possible future therapeutic treatment for the prevention and delayed progression of Alzheimer’s disease? Nutr Res Rev. 2025;38(2):613-627. PMID: 39988819
- [3] Tang W, et al. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. J Med Food. 2005;8(1):53-58. PMID: 15857210
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Functional mushroom supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any new supplement, especially if you have an existing medical condition or take prescription medications.
